"Nucleocapsid Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Viral proteins found in either the NUCLEOCAPSID or the viral core (VIRAL CORE PROTEINS).
| Descriptor ID |
D019590
|
| MeSH Number(s) |
D12.776.964.970.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleocapsid Proteins".
Below are MeSH descriptors whose meaning is more specific than "Nucleocapsid Proteins".
This graph shows the total number of publications written about "Nucleocapsid Proteins" by people in this website by year, and whether "Nucleocapsid Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 2 | 0 | 2 |
| 2003 | 5 | 4 | 9 |
| 2004 | 14 | 3 | 17 |
| 2005 | 17 | 11 | 28 |
| 2006 | 11 | 10 | 21 |
| 2007 | 12 | 2 | 14 |
| 2008 | 2 | 2 | 4 |
| 2009 | 4 | 1 | 5 |
| 2010 | 3 | 1 | 4 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 4 | 5 |
| 2013 | 3 | 3 | 6 |
| 2014 | 1 | 3 | 4 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 0 | 2 |
| 2017 | 6 | 10 | 16 |
| 2018 | 6 | 7 | 13 |
| 2019 | 1 | 2 | 3 |
| 2020 | 29 | 35 | 64 |
| 2021 | 9 | 13 | 22 |
To return to the timeline, click here.
Below are the most recent publications written about "Nucleocapsid Proteins" by people in Profiles.
-
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection. Clin Chem. 2021 12 30; 68(1):240-248.
-
Understanding structural malleability of the SARS-CoV-2 proteins and relation to the comorbidities. Brief Bioinform. 2021 11 05; 22(6).
-
Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic. Br J Dermatol. 2021 12; 185(6):1242-1244.
-
Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection. J Infect Dis. 2021 08 16; 224(4):586-594.
-
Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins. ACS Appl Mater Interfaces. 2021 Aug 25; 13(33):38990-39002.
-
Immunoassay of SARS-CoV-2 nucleocapsid proteins using novel red emission-enhanced carbon dot-based silica spheres. Analyst. 2021 Aug 09; 146(16):5055-5060.
-
Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2. J Mol Cell Biol. 2021 08 04; 13(4):259-268.
-
Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion. Braz J Microbiol. 2021 Dec; 52(4):2069-2073.
-
p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein. Pharmacol Res Perspect. 2021 08; 9(4):e00798.
-
Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies. PLoS One. 2021; 16(7):e0255208.